Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
ZYDUSLIFE's latest stock split occurred on Oct 6, 2015
The company executed a 5-for-1 stock split, meaning that for every share held, investors received 5 new shares.
Before the split, ZYDUSLIFE traded at 2081.2 per share. Afterward, the share price was about 398.26.
The adjusted shares began trading on Oct 6, 2015. This was ZYDUSLIFE's 2nd stock split, following the previous one in Apr 5, 2010.
BGLC
ATORX
TGL
Zydus Lifesciences Ltd
Glance View
Zydus Lifesciences Ltd., a resilient player in India's pharmaceutical industry, traces its origins back to 1952, when it was founded in Ahmedabad. Over the decades, it has metamorphosed from a modest venture into a global healthcare presence, with a diverse repertoire that spans across pharmaceuticals, animal health, and consumer wellness products. The company's ethos is deeply embedded in innovation, steadfastly pursuing research and development to propel its pipeline of generics, novel therapeutics, and vaccines. With a robust manufacturing infrastructure spread across continents, Zydus ensures seamless distribution and availability of its products, thereby maintaining a key foothold in both established and emerging markets. The lifeblood of Zydus's profitability streams from its comprehensive product portfolio, catering to a myriad of therapeutic areas such as cardiology, gastroenterology, and women's health, among others. It generates revenue primarily through the sale of branded generics and active pharmaceutical ingredients (APIs). Strategic alliances and collaborations further bolster its growth trajectory, providing new avenues for market expansion and technological advancements. As the firm continues to navigate the complex landscape of global healthcare demands, it remains anchored to its core mission of delivering accessible and affordable healthcare solutions, ensuring that it not only sustains its economic pulse but also positively impacts countless lives worldwide.
You don't have any saved screeners yet